Pharmacology of the Calcium Antagonist Isradipine

This publication has 12 references indexed in Scilit:

• Cerebrovascular, biochemical, and cytoprotective effects of isradipine in laboratory animals
  The American Journal of Medicine, 1989
• Treatment of hypertension with isradipine reduces infarct size following stroke in laboratory animals
  The American Journal of Medicine, 1989
• Comparison of cardiodepressant and vasodilator effects of PN 200-110 (isradipine), nifedipine and diltiazem in anesthetized rabbits
  The American Journal of Cardiology, 1987
• Calcium antagonists reduce the extent of infarction in rat middle cerebral artery occlusion model as determined by quantitative magnetic resonance imaging.
  Stroke, 1986
• SUPPRESSION OF RAT CAROTID LESION DEVELOPMENT BY THE CALCIUM-CHANNEL BLOCKER PN-200-110
  1986
• Stereoselectivity at the Calcium Channel: Different Profiles of Hemodynamic Activity of the Enantiomers of the Dihydropyridine Derivative PN 200-110
  Journal of Cardiovascular Pharmacology, 1986
• Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.
  Circulation Research, 1986
• Effects of calcium entry blockers on calcium fluxes in a vascular smooth muscle cell line.
  1985
• Effects of the New Calcium Antagonist PN 200–110 on the Myocardium and the Regional Peripheral Circulation in Anesthetized Cats and Dogs
  Journal of Cardiovascular Pharmacology, 1984
• Effects of the Calcium Antagonist PY 108–068 on Myocardial Tissues In Vitro and on Reflex Tachycardia In Vivo
  Journal of Cardiovascular Pharmacology, 1983